Danish firm wins licence to supply TB vaccinations

Vaccination News Home Page

http://www.scotlandonsunday.com/business.cfm?id=1025082002



	Sunday, 15th September 2002

Sun 15 Sep 2002

printer friendly

email article

Danish firm wins licence to supply TB vaccinations

SYLVIA PFEIFER AND ANDREW PORTER

DENMARK’S Statens Serum Institut has won a licence to sell its tuberculosis vaccine in the UK, paving the way for the government to sign it up as an emergency supplier in time for the schools vaccination programme next month.

A Department of Health spokeswoman confirmed that the Medicines Control Agency had awarded a licence to the Danish manufacturer.

The schools vaccination programme came under threat in the summer after the government’s supplier, Powderject Pharmaceuticals, withdrew its anti-TB vaccine (BCG) on concerns over its potency. It admitted then it would not be able to relaunch the vaccine before next April.

Until now Powderject, which manufactures the vaccine at its plant in Liverpool, had been the only company licensed to provide the drug in the UK.

TB has been on the increase recently after falling since the schools programme was first introduced in 1953. The number of cases fell from more than 46,000 in 1953 to 5,500 in 1987. But there were 7,300 last year.

Powderject won the £17m two-year contract in March 2001. At the time it was awarded to both Powderject and the Serum Institut, but until now the Danish firm has been unable to supply the vaccine as it has not had a UK licence.

The contract is due for renewal at the end of this year, although the Department of Health said it could extend the contract for another two years. The spokeswoman said no decision had been taken, but both Powderject and the Danish institute have already said they will be rebidding for the contract.

Government ministers have been keen to minimise the political fallout from the fiasco. Paul Drayson, Powderject’s chief executive, is a Labour party donor who came under the spotlight over allegations that the company had been awarded a £32m smallpox vaccine contract without a proper tendering process.

Meanwhile, the vaccine specialist Acambis has completed production of its smallpox vaccine for the US government and is in the final stages of packaging the doses, according to US reports.

The build-up of a store of smallpox vaccine for use in any bioterrorist attack has been a key aim in America since September 11 last year.

The extra supplies mean the US government now has enough doses to vaccinate every person in the country in the event of a biological attack.

Forth Ports harbours big growth ambitions at home and overseas

PLATFORM: Take control and make the most of IT without breaking the bank

Paying off a loan early could cost you dear

Calm voices of reason more vital than ever in a modern media world

RICHARD NORTHEDGE: Days in the City come in any colour you like as long as it’s black

MARY MacISAAC: Armchair Investor

Hammerson front runner in race for warehouse group after surprise swoop

No escape from stock market fallout for policyholders as shocks hit profits

Biotechs mull over wisdom of mergers as way forward for sector

Time running out for Royal & Sun

Price cut heralds battle for BT business custom

Further losses threaten future of UK Coal

Ravenscraig regeneration backers hit back at critics

EDITORIAL: Entrepreneurs still deserve our respect

Danish firm wins licence to supply TB vaccinations

EDITORIAL: Ravenscraig must work

Page 2 of 3

The big O
Another modern shakespearian adaptation sees Julia Stiles in a familiar role.

Step by step
Jamie Andrews lost his hands and feet climbing. So why do it again?

Join the exclusive club for real gardeners.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.

Primary Links

User login

Danish firm wins licence to supply TB vaccinations